GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 233 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $11,899,000 | +83.7% | 174,724 | -13.8% | 5.02% | +79.8% |
| Q2 2022 | $6,478,000 | -10.9% | 202,750 | -3.4% | 2.79% | +9.4% |
| Q1 2022 | $7,274,000 | +18.1% | 209,975 | -0.2% | 2.55% | +26.7% |
| Q4 2021 | $6,157,000 | +13.4% | 210,350 | -1.3% | 2.01% | +7.9% |
| Q3 2021 | $5,430,000 | -25.5% | 213,125 | +2.4% | 1.87% | -22.6% |
| Q2 2021 | $7,289,000 | -13.4% | 208,125 | +0.7% | 2.41% | -22.1% |
| Q1 2021 | $8,419,000 | -3.6% | 206,607 | +2.5% | 3.10% | -10.1% |
| Q4 2020 | $8,734,000 | -15.5% | 201,657 | +7.6% | 3.44% | -29.5% |
| Q3 2020 | $10,337,000 | -16.6% | 187,477 | -4.5% | 4.88% | -20.3% |
| Q2 2020 | $12,397,000 | +18.4% | 196,377 | -4.2% | 6.13% | -8.3% |
| Q1 2020 | $10,469,000 | -49.0% | 204,912 | -20.6% | 6.68% | -31.9% |
| Q4 2019 | $20,509,000 | +28.6% | 258,012 | -21.5% | 9.81% | +24.1% |
| Q3 2019 | $15,942,000 | -7.6% | 328,562 | +0.2% | 7.90% | -16.3% |
| Q2 2019 | $17,248,000 | +0.3% | 327,905 | +0.9% | 9.44% | +2.9% |
| Q1 2019 | $17,196,000 | +17.3% | 324,877 | -9.1% | 9.18% | -2.9% |
| Q4 2018 | $14,664,000 | +0.6% | 357,212 | -6.9% | 9.45% | +22.6% |
| Q3 2018 | $14,581,000 | -9.4% | 383,702 | +7.8% | 7.71% | -11.3% |
| Q2 2018 | $16,094,000 | -6.3% | 356,069 | +0.2% | 8.69% | -9.3% |
| Q1 2018 | $17,171,000 | +21.5% | 355,509 | -1.0% | 9.58% | +26.8% |
| Q4 2017 | $14,130,000 | +8.9% | 359,094 | -14.1% | 7.56% | -7.0% |
| Q3 2017 | $12,979,000 | +68.6% | 418,010 | +48.5% | 8.13% | +45.5% |
| Q2 2017 | $7,698,000 | -20.4% | 281,457 | +7.2% | 5.58% | -27.5% |
| Q1 2017 | $9,673,000 | +1064.0% | 262,510 | +356.7% | 7.70% | +867.5% |
| Q4 2016 | $831,000 | -9.9% | 57,484 | +43.7% | 0.80% | -5.8% |
| Q3 2016 | $922,000 | +39.3% | 40,000 | +0.3% | 0.84% | +30.2% |
| Q2 2016 | $662,000 | +109.5% | 39,900 | +100.0% | 0.65% | +102.8% |
| Q1 2016 | $316,000 | – | 19,950 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Grace Capital | 177,414 | $14,103,000 | 11.50% |
| Fernwood Investment Management, LLC | 258,012 | $20,509,000 | 9.81% |
| Perceptive Advisors | 5,865,726 | $466,266,000 | 9.26% |
| ArchPoint Investors | 186,756 | $14,845,000 | 4.54% |
| STANSBERRY ASSET MANAGEMENT, LLC | 115,638 | $9,192,000 | 3.74% |
| Camber Capital Management LP | 730,000 | $58,028,000 | 2.95% |
| Profit Investment Management, LLC | 46,873 | $3,726,000 | 2.50% |
| Casdin Capital, LLC | 300,000 | $23,847,000 | 2.19% |
| SECTORAL ASSET MANAGEMENT INC | 174,594 | $13,878,000 | 2.07% |
| Corriente Advisors, LLC | 40,000 | $3,180,000 | 1.71% |